×
About 42,272 results

EU Regulator Begins Real-time Review of First Chinese COVID-19 Vaccine
https://www.medscape.com/viewarticle/950441

May 4th, 2021 - (Reuters) - Europe's medicines regulator said on Tuesday it has started a real-time review of Sinovac's COVID-19 vaccine, based on preliminary results from animal and human trials that suggested the vaccine produces an immune response against the coronavirus. Data on the vaccine, COVID-19 Vaccine (Vero Cell) Inactivated, will be assessed as they are made available to help speed up potential app...

EU Aims to Open Up to More Foreign Tourists This Summer Despite COVID-19
https://www.medscape.com/viewarticle/950342

May 3rd, 2021 - BRUSSELS (Reuters) - The European Union's executive has recommended easing COVID-19 travel restrictions next month to let foreign travellers from more countries enter the EU, hoping to boost the stricken tourism industry this summer. Under current restrictions, people from only seven countries, including Australia and Singapore, can enter the EU on holiday, regardless of whether they have been ...

Denmark Ditches J&J COVID-19 Shots From Vaccination Programme
https://www.medscape.com/viewarticle/950362

May 3rd, 2021 - COPENHAGEN (Reuters) - Denmark on Monday became the first country to exclude Johnson & Johnson's COVID-19 shots from its vaccination programme over a potential link to a rare but serious form of blood clot. The move comes after the Nordic country last month stopped using AstraZeneca's vaccine altogether citing similar concerns.

No Regrets: AstraZeneca's Soriot Defends COVID-19 Vaccine Supply
https://www.medscape.com/viewarticle/950254

May 2nd, 2021 - LONDON (Reuters) - Pascal Soriot, who is under intense fire from the European Union over the delivery of AstraZeneca's COVID-19 vaccines, said on Friday the drugmaker he runs had not overpromised on the supply of shots. The European Commission has launched legal proceedings against the Anglo-Swedish drugmaker, alleging that it did not respect its contract or have a "reliable" plan to ensure tim...

Some EU Nations Still Want Valneva COVID-19 Vaccine Deal: Sources
https://www.medscape.com/viewarticle/950292

May 2nd, 2021 - PARIS (Reuters) - Some EU countries still want Brussels to strike a deal to buy Valneva's COVID-19 vaccine candidate despite a recent setback in talks, as the bloc aim to shore up and diversify supplies, sources familiar with the talks told Reuters. A spokesman for the European Commission said last week the French vaccine maker had not met conditions required to reach an agreement, two days aft...

EMA to Quickly Review Eli Lilly, Incyte Arthritis Drug for COVID-19 Use
https://www.medscape.com/viewarticle/950192

Apr 29th, 2021 - ZURICH (Reuters) - The European Medicines Agency will conduct an accelerated review of Eli Lilly and Co's rheumatoid arthritis drug Olumiant for hospitalized COVID-19 patients getting oxygen, the agency said on Thursday, as the search for treatment options continues. Olumiant, on which Lilly partners with U.S. drugmaker Incyte Corp, is the latest arthritis medicine to be repurposed in efforts t...

BioNTech Expects Vaccine Trial Results for Babies by September
https://www.medscape.com/viewarticle/950183

Apr 29th, 2021 - BERLIN (Reuters) - BioNTech expects results by September from trials testing the COVID-19 vaccine that it and Pfizer have developed in babies as young as six months old, German magazine Spiegel cited the company's CEO as saying. "In July, the first results could be available for the five to 12 year olds, in September for the younger children," BioNTech Chief Executive Ugur Sahin told Spiegel. H...

Danish Official Calls AstraZeneca 'Ethical' Option for Some Nations
https://www.medscape.com/viewarticle/950203

Apr 29th, 2021 - ZURICH (Reuters) - Denmark's top health official said on Thursday "the only ethical, correct decision" for some countries facing COVID-19 crises is to continue giving AstraZeneca's vaccine, though his nation halted use over very rare clotting concerns. Soren Brostrom, speaking at a Danish Health Authority-sponsored scientific conference over the clotting, was responding to a question over wheth...

Novavax's COVID-19 Vaccine May Be Authorized Next
https://www.medscape.com/viewarticle/950186

Apr 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Novavax's COVID-19 vaccine may be the next shot to receive emergency authorization in the U.S., according to Politico. The company is preparing to file the FDA paperwork in coming weeks and could beat out other vaccine manufacturers such as AstraZeneca. Public health officials and researchers se...

Waivers for Vaccine Production 'Not a Solution': BioNTech
https://www.medscape.com/viewarticle/950078

Apr 28th, 2021 - BERLIN (Reuters) - The granting of intellectual property waivers is not the right way to increase output of COVID-19 vaccines, the founder of German vaccine maker BioNTech said on Wednesday, advocating instead the award of production licences. Such waivers are among the options being considered by the Biden administration for maximising the production and supply of vaccines, though no decision ...

Small Cell Lung Cancer Clinical Practice Guidelines (ESMO, 2021)
https://reference.medscape.com/viewarticle/950185

Apr 28th, 2021 - Updated guidelines on diagnosis, treatment, and follow-up of small cell lung cancer (SCLC) were published on April 9, 2021 by the European Society for Medical Oncology (ESMO) in the Annals of Oncology.[1] Diagnosis SCLC should be diagnosed according to the World Health Organization criteria. Currently, no predictive biomarker is available and programmed death-ligand 1 (PD-L1) and tumor mutation...

EU Official Warns of Risks of Disjointed COVID Vaccine Records
https://www.medscape.com/viewarticle/950093

Apr 28th, 2021 - BRUSSELS (Reuters) - European Union countries introducing their own COVID vaccination certificates would have to grapple with a myriad of disjointed systems if the bloc fails to build a shared one, a senior official said on Wednesday. The EU is pushing to have a shared digital health pass to allow tourists to travel freely this summer. But discussions are not yet settled on costs, data and priv...

Brazil Health Regulator Rejects Russia's Sputnik Vaccine
https://www.medscape.com/viewarticle/950002

Apr 27th, 2021 - BRASILIA/MOSCOW (Reuters) - The Brazilian health regulator Anvisa on Monday rejected importing the Russian-made Sputnik V COVID-19 vaccine requested by state governors battling a deadly second wave of the virus that is battering Latin America's largest nation. Anvisa's five-strong board voted unanimously not to approve the Russian vaccine after technical staff had highlighted "inherent risks" a...

Some Russians Get Extra COVID-19 Shots. Sputnik V Developers Say No Need
https://www.medscape.com/viewarticle/950003

Apr 27th, 2021 - MOSCOW (Reuters) - Some Russians who have taken COVID-19 antibody tests and found their antibodies have fallen are having third and fourth shots of the Sputnik V vaccine, but researchers in the country suggest they are unnecessary. Revaccination in effect simulates getting the disease so that the body develops more antibodies to fight it. Researchers have said an immediate rise in antibodies se...

Novartis Could Boost CureVac Vaccine Production, if Needed: CEO
https://www.medscape.com/viewarticle/950018

Apr 27th, 2021 - ZURICH (Reuters) - Novartis is scaling up facilities to make COVID-19 vaccine doses for German drugmaker CureVac and could boost production beyond levels agreed so far, Chief Executive Vas Narasimhan said on a conference call on Tuesday. Novartis aims to produce up to 50 million doses in 2021 and up to a further 200 million doses in 2022 for CureVac at its facilities in Austria's Tyrol region n...

EU Sues AstraZeneca Over Delayed Deliveries of COVID-19 Vaccine
https://www.medscape.com/viewarticle/949936

Apr 26th, 2021 - BRUSSELS (Reuters) - The European Commission said on Monday it had launched legal action against AstraZeneca for not respecting its contract for the supply of COVID-19 vaccines and for not having a "reliable" plan to ensure timely deliveries. AstraZeneca said in response that the legal action by the EU was without merit and pledged to defend itself strongly in court. "AstraZeneca has fully comp...

US to Share Up to 60 Mln AstraZeneca Vaccine Doses Globally: White House
https://www.medscape.com/viewarticle/949981

Apr 26th, 2021 - WASHINGTON (Reuters) - The United States will start to share up to 60 million doses of AstraZeneca Plc's coronavirus vaccine with other countries as soon as the next few weeks, the White House said on Monday. White House Press Secretary Jen Psaki said the United States would release the doses to other countries as they become available. She said there could be 10 million doses cleared for expor...

Viable Plan or Security Theatre? Europe Embraces Digital Health Pass
https://www.medscape.com/viewarticle/949938

Apr 26th, 2021 - MADRID (Reuters) - As Europe races to set up a digital health pass program to save the holiday season from the pandemic, technical and political obstacles are showing just how big a challenge the world faces in building such systems, people involved in the effort say. Developers are grappling with issues ranging from the practical - such as what to accept as proof of being COVID-19 free - to th...

How the EU's Digital Health Pass Program Would Work
https://www.medscape.com/viewarticle/949939

Apr 26th, 2021 - (Reuters) - Europe plans to launch a digital health pass program in June that it hopes will save this summer's holiday season by making it possible for travellers to prove they have been vaccinated against, or tested negative for, COVID-19. HOW WOULD IT WORK? The pass, issued by a doctor or health centre, would feature a QR code containing pre-authenticated information that a traveller has been...

European Union to Allow Vaccinated US Tourists This Summer
https://www.medscape.com/viewarticle/949971

Apr 25th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. US tourists who have been fully vaccinated against COVID-19 will be able to visit countries in the European Union this summer, according to The New York Times. The European Commission, which is the executive branch of the bloc, will recommend a switch in policy after more than a year of restrict...